Journal article
The significance of FOXP1 in diffuse large B-cell lymphoma
- Abstract:
-
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of mature B-cell lymphoma. While the majority of patients are cured with immunochemotherapy incorporating the anti-CD20 monoclonal antibody rituximab (R-CHOP), relapsed and refractory patients still have a dismal prognosis. DLBCL subtypes including an aggressive activated B-cell-like (ABC) and a more favourable prognosis germinal centre-like (GCB) DLBCL have been identified by gene expression profiling and are characterised by d...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted manuscript
Actions
Access Document
- Files:
-
-
(pdf, 1.5MB)
-
- Publisher copy:
- 10.1080/10428194.2016.1228932
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Bibliographic Details
- Publisher:
- Taylor and Francis Publisher's website
- Journal:
- Leukemia and Lymphoma Journal website
- Volume:
- 58
- Issue:
- 5
- Pages:
- 1037-1051
- Publication date:
- 2016-09-05
- Acceptance date:
- 2016-08-23
- DOI:
- EISSN:
-
1029-2403
- ISSN:
-
1042-8194
- Pubs id:
-
pubs:641717
- URN:
-
uri:0af296cc-ed42-4dea-8457-9dc26cb1c00a
- UUID:
-
uuid:0af296cc-ed42-4dea-8457-9dc26cb1c00a
- Local pid:
- pubs:641717
Terms of use
- Copyright holder:
- Gascoyne and Banham
- Copyright date:
- 2016
- Notes:
- © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor and Francis Group.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unre-stricted use, distribution, and reproduction in any medium, provided the original work is properly cited
If you are the owner of this record, you can report an update to it here: Report update to this record